scorecardresearch
Sunday, July 20, 2025
TopicIndian drugmaker

Topic: Indian drugmaker

Indian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—McKinsey report

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.

Tax doctors on research grants by drugmakers, says govt panel reviewing pharma marketing practices

Five-member panel suggests doctors can't be given brand reminders exceeding Rs 1,000 each, Uniform Code of Pharmaceutical Marketing Practices to remain voluntary, but strengthened.

Sun Pharmaceutical flags revenue drop in its businesses due to ‘IT security incident’

The incident’s effect included breach of certain file systems and theft of some company and personal data, Sun Pharma said in a filing on Sunday.

On Camera

Dear Tesla buyers, Don’t crib about high tariffs. They have helped Indian auto industry

Since BMW assembles at its Chennai factory, it’s able to price the iX1 at Rs 49 lakh. It's much more affordable and practical than Tesla.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.